Nandrolone Decanoate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08804 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 2 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 3 | autoimmune oophoritis | KG + DL |
| 4 | diabetic nephropathy | KG + DL |
| 5 | type 1 diabetes mellitus | KG + DL |
| 6 | cholecystolithiasis | KG + DL |
| 7 | obsolete hyperuricemia (disease) | KG + DL |
| 8 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 9 | scalp dermatosis | KG + DL |
| 10 | hyperthyroidism | KG + DL |
| 11 | kyphoscoliotic heart disease | KG + DL |
| 12 | pulmonary hypertension | KG + DL |
| 13 | female breast carcinoma | KG + DL |
| 14 | primary hereditary glaucoma | KG + DL |
| 15 | Lesch-Nyhan syndrome | KG + DL |
| 16 | hypouricemia, renal | KG + DL |
| 17 | hypoxanthine guanine phosphoribosyltransferase partial deficiency | KG + DL |
| 18 | cor pulmonale | KG + DL |
| 19 | hyperthyroxinemia | KG + DL |
| 20 | open-angle glaucoma | KG + DL |
| 21 | gout | KG + DL |
| 22 | Jeune syndrome situs inversus | KG + DL |
| 23 | orofacial clefting syndrome | KG + DL |
| 24 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 25 | Laubry-Pezzi syndrome | KG + DL |
| 26 | disorder of fucoglycosan synthesis | KG + DL |
| 27 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 28 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 29 | heart conduction disease | KG + DL |
| 30 | interventricular septum aneurysm | KG + DL |
| 31 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 32 | tendinitis | KG + DL |
| 33 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 34 | allergic asthma | KG + DL |
| 35 | pulmonary valve disease | KG + DL |
| 36 | heart valve disease | KG + DL |
| 37 | mitral valve disease | KG + DL |
| 38 | heart disease | KG + DL |
| 39 | vulvar inverted follicular keratosis | KG + DL |
| 40 | idiopathic granulomatous myositis | KG + DL |
| 41 | myositis fibrosa | KG + DL |
| 42 | mycotic corneal ulcer | KG + DL |
| 43 | heart neoplasm | KG + DL |
| 44 | ocular tuberculosis | KG + DL |
| 45 | congenital anomaly of ventricular septum | KG + DL |
| 46 | mitral valve stenosis | KG + DL |
| 47 | anuria | KG + DL |
| 48 | intrinsic asthma | KG + DL |
| 49 | seborrheic keratosis | KG + DL |
| 50 | genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.